Pivotal role of CD103 in the development of psoriasiform dermatitis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 05 2020
Historique:
received: 25 09 2019
accepted: 30 04 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 15 12 2020
Statut: epublish

Résumé

The integrin αE known as CD103 binds integrin β7 to form the complete heterodimeric integrin molecule αEβ7. CD103 is mainly expressed by lymphocytes within epithelial tissues of intestine, lung, and skin as well as subsets of mucosal and dermal conventional dendritic cells (cDCs). CD103 has been originally implicated in the attachment of lymphocytes to epithelium in the gut and skin through the interaction with E-cadherin expressed on intestinal epithelial cells, keratinocytes, and Langerhans cells (LCs). However, an impact of CD103 on the cutaneous immune responses and the development of inflammatory skin diseases remains elusive. Here, we report that CD103 regulates the development of psoriasiform dermatitis through the control of the function of cDCs. Deficiency in CD103 exacerbates psoriasiform dermatitis, accompanied by excessive epidermal hyperplasia and infiltration of inflammatory leukocytes. Furthermore, deficiency in CD103 not only accelerates the production of proinflammatory cytokines in psoriatic lesions but also promotes the generation of lymphocytes producing interleukin (IL)-17 in the skin-draining peripheral lymph nodes (PLNs). Under the deficiency in CD103, cDCs localized in PLNs enhance cytokine production following activation. Thus, our findings reveal a pivotal role for CD103 in the control of the function of cDCs to regulate cutaneous inflammation in psoriasiform dermatitis.

Identifiants

pubmed: 32433498
doi: 10.1038/s41598-020-65355-9
pii: 10.1038/s41598-020-65355-9
pmc: PMC7239860
doi:

Substances chimiques

Antigens, CD 0
Integrin alpha Chains 0
alpha E integrins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8371

Commentaires et corrections

Type : ErratumIn

Références

Guilliams, M. et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14, 571–578 (2014).
doi: 10.1038/nri3712
Murphy, T. L. et al. Transcriptional control of dendritic cell development. Annu. Rev. Immunol. 34, 93–119 (2016).
doi: 10.1146/annurev-immunol-032713-120204
Sato, K., Uto, T., Fukaya, T. & Takagi, H. Regulatory dendritic cells. Curr. Top. Microbiol. Immunol. 410, 47–71 (2017).
pubmed: 28900681
Takagi, H. et al. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35, 958–971 (2011).
doi: 10.1016/j.immuni.2011.10.014
Pasparakis, M., Haase, I. & Nestle, F. O. Mechanisms regulating skin immunity and inflammation. Nat. Rev. Immunol. 14, 289–301 (2014).
doi: 10.1038/nri3646
Lowes, M. A., Suárez-Fariñas, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227–255 (2014).
doi: 10.1146/annurev-immunol-032713-120225
Gilliet, M. & Lande, R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol. 20, 401–407 (2008).
doi: 10.1016/j.coi.2008.06.008
Lai, Y. et al. The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity 37, 74–84 (2012).
doi: 10.1016/j.immuni.2012.04.010
Cai, Y. et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 35, 596–610 (2011).
doi: 10.1016/j.immuni.2011.08.001
Glitzner, E. et al. Specific roles for dendritic cell subsets during initiation and progression of psoriasis. EMBO Mol. Med. 6, 1312–1327 (2014).
doi: 10.15252/emmm.201404114
Takagi, H. et al. Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation. Sci. Rep. 6, 24477 (2016).
doi: 10.1038/srep24477
Kumari, S. et al. Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice. Immunity 39, 899–911 (2013).
doi: 10.1016/j.immuni.2013.10.009
van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836–5845 (2009).
doi: 10.4049/jimmunol.0802999
Lowes, M. A. et al. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 34, 174–181 (2013).
doi: 10.1016/j.it.2012.11.005
Pantelyushin, S. et al. Rorγt
doi: 10.1172/JCI61862
Fukaya, T. et al. Pivotal role of IL-22 binding protein in the epithelial autoregulation of interleukin-22 signaling in the control of skin inflammation. Front. Immunol. 9, 1418 (2018).
doi: 10.3389/fimmu.2018.01418
Cepek, K. L. et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 372, 190–103 (1994).
doi: 10.1038/372190a0
Karecla, P. I., Bowden, S. J., Green, S. J. & Kilshaw, P. J. Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin αM290β7 (αEβ7). Eur. J. Immunol. 25, 852–856 (1995).
doi: 10.1002/eji.1830250333
Kilshaw, P. J. & Higgins, J. M. Alpha E: no more rejection? J. Exp. Med. 19, 873–875 (2002).
doi: 10.1084/jem.20021404
Schön, M. P. et al. Cutaneous inflammatory disorder in integrin αE (CD103)-deficient mice. J. Immunol. 165, 6583–6589 (2000).
doi: 10.4049/jimmunol.165.11.6583
Schön, M. P. et al. Mucosal T lymphocyte numbers are selectively reduced in integrin αE (CD103)-deficient mice. J Immunol. 162, 6641–6649 (1999).
pubmed: 10352281
Schön, M. P., Schön, M., Parker, C. M. & Williams, I. R. Dendritic epidermal T cells (DETC) are diminished in integrin αE(CD103)-deficient mice. J. Invest. Dermatol. 119, 190–193 (2002).
doi: 10.1046/j.1523-1747.2002.17973.x
Feng, Y. et al. CD103 expression is required for destruction of pancreatic islet allografts by CD8
doi: 10.1084/jem.20020178
El-Asady, R. et al. TGF-β-dependent CD103 expression by CD8
doi: 10.1084/jem.20041044
Bernatchez, E. et al. Pulmonary CD103 expression regulates airway inflammation in asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L816–L826 (2015).
doi: 10.1152/ajplung.00319.2014
Fousteri, G. et al. Minimal effect of CD103 expression on the control of a chronic antiviral immune response. Viral Immunol. 23, 285–294 (2010).
doi: 10.1089/vim.2009.0110
Mullaly, S. C., Burrows, K., Antignano, F. & Zaph, C. Assessing the role of CD103 in immunity to an intestinal helminth parasite. PLoS One 6, e19580 (2011).
doi: 10.1371/journal.pone.0019580
Braun, A. et al. Integrin αE(CD103) is involved in regulatory T-cell function in allergic contact hypersensitivity. J. Invest. Dermatol. 135, 2982–2991 (2015).
doi: 10.1038/jid.2015.287
Braun, A. et al. Integrin αE(CD103) is induced but plays no pathogenic role in psoriasiform skin lesions of TGFβ1 transgenic mice. Exp. Dermatol. 25, 311–313 (2016).
doi: 10.1111/exd.12958

Auteurs

Takehito Fukui (T)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Department of Oral and Maxillofacial Surgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.

Tomohiro Fukaya (T)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Japan Agency for Medical Research and Development (AMED), 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.

Tomofumi Uto (T)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Japan Agency for Medical Research and Development (AMED), 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.

Hideaki Takagi (H)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Japan Agency for Medical Research and Development (AMED), 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.

Junta Nasu (J)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Department of Oral and Maxillofacial Surgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.

Noriaki Miyanaga (N)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine,University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.

Yotaro Nishikawa (Y)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Department of Dermatology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.

Haruhiko Koseki (H)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.

Narantsog Choijookhuu (N)

Division of Histochemistry and Cell Biology, Department of Anatomy, Faculty of Medicine, University of Miyazaki, Miyazaki, 889-1692, Japan.

Yoshitaka Hishikawa (Y)

Division of Histochemistry and Cell Biology, Department of Anatomy, Faculty of Medicine, University of Miyazaki, Miyazaki, 889-1692, Japan.

Yoshihiro Yamashita (Y)

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.

Katsuaki Sato (K)

Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan. katsuaki_sato@med.miyazaki-u.ac.jp.
Japan Agency for Medical Research and Development (AMED), 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan. katsuaki_sato@med.miyazaki-u.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH